These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 16331493

  • 1. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
    Li M, Wang H, Hill DL, Stinson S, Veley K, Grossi I, Peggins J, Covey JM, Zhang R.
    Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
    [Abstract] [Full Text] [Related]

  • 2. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.
    Wang H, Li M, Rhie JK, Hockenbery DM, Covey JM, Zhang R, Hill DL.
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820
    [Abstract] [Full Text] [Related]

  • 3. Preclinical pharmacology of epothilone D, a novel tubulin-stabilizing antitumor agent.
    Wang H, Wang Z, Wang S, Li M, Nan L, Rhie JK, Covey JM, Zhang R, Hill DL.
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):255-60. PubMed ID: 15868148
    [Abstract] [Full Text] [Related]

  • 4. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2.
    Zhang Y, Hua Y, Benbrook DM, Covey JM, Dai G, Liu Z, Chan KK.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614
    [Abstract] [Full Text] [Related]

  • 5. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.
    Adams WJ, McGovren JP, Dalm EA, Brewer JE, Hosley JD.
    Cancer Res; 1989 Nov 15; 49(22):6328-36. PubMed ID: 2529962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M, Lees P, Seewald W, King JN.
    J Vet Pharmacol Ther; 2009 Feb 15; 32(1):41-8. PubMed ID: 19161454
    [Abstract] [Full Text] [Related]

  • 10. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
    Aneja R, Dhiman N, Idnani J, Awasthi A, Arora SK, Chandra R, Joshi HC.
    Cancer Chemother Pharmacol; 2007 Nov 15; 60(6):831-9. PubMed ID: 17285314
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
    Leung KH, Cohn DA, Miller RR, Doss GA, Stearns RA, Simpson RE, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1996 Jul 15; 24(7):753-60. PubMed ID: 8818572
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
    Jia L, Coward LC, Kerstner-Wood CD, Cork RL, Gorman GS, Noker PE, Kitada S, Pellecchia M, Reed JC.
    Cancer Chemother Pharmacol; 2008 Jan 15; 61(1):63-73. PubMed ID: 17356822
    [Abstract] [Full Text] [Related]

  • 15. Proteomic analysis identifies oxidative stress induction by adaphostin.
    Stockwin LH, Bumke MA, Yu SX, Webb SP, Collins JR, Hollingshead MG, Newton DL.
    Clin Cancer Res; 2007 Jun 15; 13(12):3667-81. PubMed ID: 17575232
    [Abstract] [Full Text] [Related]

  • 16. Bioavailability and pharmacokinetics of the cardioprotecting flavonoid 7-monohydroxyethylrutoside in mice.
    Abou El Hassan MA, Kedde MA, Zwiers UT, Tourn E, Haenen GR, Bast A, van der Vijgh WJ.
    Cancer Chemother Pharmacol; 2003 Nov 15; 52(5):371-6. PubMed ID: 12898182
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disposition of abouthiouzine: a novel antihyperthyroid drug.
    Alkharfy KM, Khan RM, Al-Hadiya BM, Abou-Auda HS, Abou-Shaaban RR.
    Biopharm Drug Dispos; 2007 Apr 15; 28(3):105-11. PubMed ID: 17230598
    [Abstract] [Full Text] [Related]

  • 19. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
    Newman RA, Fuentes A, Covey JM, Benvenuto JA.
    Drug Metab Dispos; 1994 Apr 15; 22(3):428-32. PubMed ID: 8070319
    [Abstract] [Full Text] [Related]

  • 20. Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide.
    Germann N, Urien S, Rodgers AH, Ratterree M, Struck RF, Waud WR, Serota DG, Bastian G, Jursic BS, Morgan LR.
    Cancer Chemother Pharmacol; 2005 Feb 15; 55(2):143-51. PubMed ID: 15592722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.